Zenas BioPharma Announces Upsized $200 Million Series C Financing to Advance Mid- and Late-Stage Immunology-Focused Clinical Development Programs
Globe Newswire7-05-2024, 18:00
The Evolving Global Landscape in Vaccine Development: 15-02-2023, 18:22